1. Home
  2. OCS vs MTAL Comparison

OCS vs MTAL Comparison

Compare OCS & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • MTAL
  • Stock Information
  • Founded
  • OCS 2003
  • MTAL 2021
  • Country
  • OCS Switzerland
  • MTAL Jersey
  • Employees
  • OCS N/A
  • MTAL N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • MTAL Blank Checks
  • Sector
  • OCS Health Care
  • MTAL Finance
  • Exchange
  • OCS Nasdaq
  • MTAL Nasdaq
  • Market Cap
  • OCS 956.4M
  • MTAL 997.3M
  • IPO Year
  • OCS N/A
  • MTAL 2021
  • Fundamental
  • Price
  • OCS $17.64
  • MTAL $12.03
  • Analyst Decision
  • OCS Strong Buy
  • MTAL Hold
  • Analyst Count
  • OCS 3
  • MTAL 4
  • Target Price
  • OCS $35.33
  • MTAL $12.08
  • AVG Volume (30 Days)
  • OCS 13.6K
  • MTAL 564.7K
  • Earning Date
  • OCS 08-26-2025
  • MTAL 07-23-2025
  • Dividend Yield
  • OCS N/A
  • MTAL N/A
  • EPS Growth
  • OCS N/A
  • MTAL N/A
  • EPS
  • OCS N/A
  • MTAL N/A
  • Revenue
  • OCS $847,333.00
  • MTAL $340,736,000.00
  • Revenue This Year
  • OCS $10.23
  • MTAL $18.41
  • Revenue Next Year
  • OCS $912.87
  • MTAL $23.55
  • P/E Ratio
  • OCS N/A
  • MTAL N/A
  • Revenue Growth
  • OCS N/A
  • MTAL 114.30
  • 52 Week Low
  • OCS $10.79
  • MTAL $7.69
  • 52 Week High
  • OCS $23.08
  • MTAL $14.31
  • Technical
  • Relative Strength Index (RSI)
  • OCS 40.60
  • MTAL 54.08
  • Support Level
  • OCS $17.27
  • MTAL $12.05
  • Resistance Level
  • OCS $18.57
  • MTAL $12.12
  • Average True Range (ATR)
  • OCS 0.53
  • MTAL 0.07
  • MACD
  • OCS 0.01
  • MTAL -0.03
  • Stochastic Oscillator
  • OCS 31.11
  • MTAL 27.78

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About MTAL Metals Acquisition Limited

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.

Share on Social Networks: